menu
    • menu

    Company profile for Rocket Pharmaceuticals

    NEW Drugs in Dev: 6
    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    Boai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    Nanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

    Virtual Booth

    Contact Supplier

    Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Best-in-class curative gene & cell therapies for patients with devastating diseases. Rocket’s pipeline is comprised of first-in-class gene therapies for rare & devastating inherited diseases. Designed in collaboration with leading academic and industry partners, Rocket lentiviral-based programs aim to enable transduction of patients’ stem cells by means of 3rd-generation, self-inactivating lentiviral vectors to optimize th...
    Best-in-class curative gene & cell therapies for patients with devastating diseases. Rocket’s pipeline is comprised of first-in-class gene therapies for rare & devastating inherited diseases. Designed in collaboration with leading academic and industry partners, Rocket lentiviral-based programs aim to enable transduction of patients’ stem cells by means of 3rd-generation, self-inactivating lentiviral vectors to optimize the potential for gene-correction & stem cell engraftment such that the functional deficits of each disorder are corrected, with sufficient quantities of healthy protein manufactured by patients’ own hematopoietic cells.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Rocket PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    The Empire State Building 350 Fifth Avenue Suite 7530 New York, NY 10118
    Telephone
    Telephone
    646.440.9100
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://rocketpharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/rocket-pharmaceuticals-ltd
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Rocket Pharmaceuticals Reports Q1 2026 Results and Progress
    Rocket Pharmaceuticals Reports Q1 2026 Results and Progress

    07 May 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-05-07/rocket-pharmaceuticals-reports-first-quarter-2026-financial-results-and-highlights-recent-progress

    PHARMIWEB
    07 May 2026
    Share Share
    Rocket Pharma Announces $180 M Sale of Priority Review Voucher
    Rocket Pharma Announces $180 M Sale of Priority Review Voucher

    28 Apr 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-04-28/rocket-pharmaceuticals-announces-180-million-sale-of-priority-review-voucher

    PHARMIWEB
    28 Apr 2026
    Share Share
    Rocket Pharma Announces FDA Approval of Kresladi
    Rocket Pharma Announces FDA Approval of Kresladi

    28 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-27/rocket-pharmaceuticals-announces-fda-approval-of-kresladi-for-pediatric-patients-with-severe-leukoc

    PHARMIWEB
    28 Mar 2026
    Share Share
    Rocket Pharma to Participate in Upcoming Investor Conferences
    Rocket Pharma to Participate in Upcoming Investor Conferences

    23 Feb 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-02-23/rocket-pharmaceuticals-to-participate-in-upcoming-investor-conferences

    PHARMIWEB
    23 Feb 2026
    Share Share
    JPM Day 3: Rare Disease In The Spotlight
    JPM Day 3: Rare Disease In The Spotlight

    15 Jan 2026

    // BIOSPACE

    https://www.biospace.com/business/jpm-day-3-rare-disease-in-the-spotlight

    BIOSPACE
    15 Jan 2026
    Share Share
    Rocket Pharma at 44th J.P. Morgan Healthcare Conference
    Rocket Pharma at 44th J.P. Morgan Healthcare Conference

    05 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260105175291/en/Rocket-Pharmaceuticals-to-Participate-in-the-44th-Annual-J.P.-Morgan-Healthcare-Conference

    BUSINESSWIRE
    05 Jan 2026
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search